Cardiotoxicity of BTK inhibitors: ibrutinib and beyond-Reference-Cited by-同舟云学术

Cardiotoxicity of BTK inhibitors: ibrutinib and beyond

Published:2022-04-03 Issue:4 Volume:15 Page:321-331
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Christensen Bradley W.¹,Zaha Vlad G²,Awan Farrukh T.¹^ORCID

Affiliation:

1. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical CenterHarold C. , Dallas, TX, USA

2. Division of Cardiovascular Medicine, Department of Medicine, Advanced Imaging Research Center, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA

Funder

No funding

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2022.2067526

Reference105 articles.

1. Structure-Function Relationships of Covalent and Non-Covalent BTK Inhibitors

2. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases

3. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages

4. The Tec family of cytoplasmic tyrosine kinases: mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other species

5. Comparative Analysis of BTK Inhibitors and Mechanisms Underlying Adverse Effects

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitors;Critical Reviews in Oncology/Hematology;2024-09

2. Ibrutinib and venetoclax in combination for chronic lymphocytic leukemia: synergy in practice;Blood Neoplasia;2024-09

3. Bruton tyrosine kinase inhibitor-related atrial fibrillation and its implications in the treatment of B-cell lymphoma;Frontiers in Cardiovascular Medicine;2024-07-26

4. A retrospective observational study of ibrutinib in chronic lymphocytic leukaemia in a real-life setting in France using the national claims database (OSIRIS);Annals of Hematology;2024-07-05

5. Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study;Blood Advances;2024-04-26